See the video
Relive our Bloody Great Night!
View Now
Support Us
There are many ways you can get behind us!
Find out how
Subscribe
Get updates on our news and events
Join email list now
About Us
Foundation for A
Bloody Great Cause
We raise funds to support the world-leading blood cancer clinical trials at Concord Cancer Centre, Concord Hospital – giving more patients a greater hope for a cure.
- Largest clinical research unit for blood cancers in NSW
- International reputation for quality and independence
- Treating patients with cutting-edge therapies
- Access to new treatments, long before they’re publicly available
“Finding cures. Saving Lives.”
The Foundation for A Bloody Great Cause are thrilled to announce Canada Bay Club as the Diamond Sponsor for their gala event...
"Bloody Great Night Out! 18 October 2024
The Foundation are thrilled to announce our major Diamond sponsor for 2024 is Canada Bay Club. Their sponsorship will start our fundraising which will conclude with an amazing dinner - The Bloody Great Night Out! on 18 October 2024
Latest News
Our recent activities and achievements
24 March 2025
The Bloody Great Committee and the Foundation hosted its 6th annual International Women’s Day breakfast.
13 February 2025
Dr Nicole Wong Doo and Professor Judith Trotman, haematologists at Concord Hospital who are passionate about improving the quality of life for lymphoma patients, have announced the launch of the Myhodgkin Myhealth app.
1 July 2024
The Foundation for A Bloody Great Cause are thrilled to announce Canada Bay Club as the Diamond Sponsor for their gala event A Bloody Great Night Out! 18 October 2024
Follow Us on Social Media
Stay up to date about A Bloody Great Night Out!
@abloodygreatcause
@ABloodyGr8Cause
@abloodygreatcause
10,000
Australians diagnosed with blood cancer each year
1000
blood cancer patients have participated in clinical trials at Concord Hospital
140
blood cancer clinical trials have been conducted at Concord Hospital
Our Target
Every $80,000 we raise, funds one clinical
research nurse for 12 months.
Every additional nurse means more opportunities for blood cancer patients
to participate in our world-leading clinical trials and access innovative
medicines long before they are publicly available.
